|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01833 PA GOODDOCTOR
Nominal 
11.780 +0.220 (+1.903%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 2,093,449 | -5.793% | 2,222,177 | 2,830,955 | 3,818,356 | 2,746,645 |
| Cost of Sales | (1,419,651) | -5.785% | (1,506,815) | (2,079,317) | (2,793,137) | (1,925,042) |
| Gross Profit | 673,798 | -5.810% | 715,362 | 751,638 | 1,025,219 | 821,603 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (268) | -88.903% | (2,415) | (35,131) | (9,692) | (54,913) | |
| Profit / (Loss) before Taxation | 60,652 | -- | (244,263) | (460,403) | (870,658) | (209,021) | |
| Taxation | (23) | -96.192% | (604) | (3,538) | (8,685) | (4,184) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (3,981) | -- | 249 | 1,486 | (216) | (381) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 56,648 | -- | (244,618) | (462,455) | (879,559) | (213,586) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (102,436) | -19.544% | (127,319) | (140,043) | (167,235) | (131,315) |
| Depreciation & Amortisation | 52,529 | -38.293% | 85,126 | 104,218 | 101,238 | 81,522 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 5.000 | -- | -23.000 | -43.000 | -80.000 | -21.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 11.958 | -- | 11.933 | 12.098 | 13.081 | 8.887 |
| Remarks: | Real time quote last updated: 04/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 56,648 |
| %Change | -- |
| EPS / (LPS) | RMB 0.050 |
| NBV Per Share (¥) | RMB 11.958 |